ID

15552

Description

Phase 1b/2 Study of Selinexor (KPT-330) in Combination w/ Backbone Treatments for Resistant/Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT02343042

Lien

https://clinicaltrials.gov/show/NCT02343042

Mots-clés

Versions (2)
  1. 03/06/2016 03/06/2016 -
  2. 03/06/2016 03/06/2016 - Julian Varghese
Téléchargé le

3 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Multiple Myeloma NCT02343042

Anglais

Eligibility Multiple Myeloma NCT02343042

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed diagnosis, measurable disease and evidence of disease progression of multiple myeloma, as described below.
Description

Diagnosis Histology | Measurable Disease | Multiple Myeloma | Disease Progression

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0344441
UMLS CUI [2]
C1513041
UMLS CUI [3]
C0026764
UMLS CUI [4]
C0242656
symptomatic multiple myeloma, based on imwg guidelines. patients must have measurable disease as defined by at least one of the following:
Description

Multiple Myeloma Symptomatic | Measurable Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0231220
UMLS CUI [2]
C1513041
1. serum m-protein ≥ 5 g/l by serum electrophoresis (spep) or for immunoglobulin a (iga) myeloma, by quantitative iga; or
Description

M Protein | Serum protein electrophoresis | IgA myeloma | Immunoglobulin A measurement Quantitative

Type de données

boolean

Alias
UMLS CUI [1]
C0700271
UMLS CUI [2]
C0201720
UMLS CUI [3]
C0563305
UMLS CUI [4,1]
C0202083
UMLS CUI [4,2]
C0392762
2. urinary m-protein excretion at least 200 mg/24 hours; or
Description

Excretion measurement M Protein In Urine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0201808
UMLS CUI [1,2]
C0700271
UMLS CUI [1,3]
C0042037
3. involved serum free light chains ≥ 100 mg/l, provided that free light chain ratio is abnormal
Description

Serum Free Immunoglobulin Light Chain Involvement | Serum Immunoglobulin Free Light Chain Ratio Abnormal

Type de données

boolean

Alias
UMLS CUI [1,1]
C2827352
UMLS CUI [1,2]
C1314939
UMLS CUI [2]
C2826181
4. if serum protein electrophoresis is felt to be unreliable for routine m-protein measurement, then quantitative immunoglobulin levels by nephelometry or turbidometry are acceptable.
Description

Serum protein electrophoresis unreliable | M Protein Measurement | Immunoglobulin level Quantitative | Nephelometry | Turbidimetry

Type de données

boolean

Alias
UMLS CUI [1,1]
C0201720
UMLS CUI [1,2]
C0749770
UMLS CUI [2,1]
C0700271
UMLS CUI [2,2]
C0242485
UMLS CUI [3,1]
C0428536
UMLS CUI [3,2]
C0392762
UMLS CUI [4]
C0027692
UMLS CUI [5]
C0041394
resolution of prior drug-related toxicities to ≤ grade 1.
Description

Resolution Toxic effect Due to Pharmaceutical Preparations

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514893
UMLS CUI [1,2]
C0600688
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0013227
relapsed and/or refractory multiple myeloma.
Description

Multiple Myeloma Relapsed | Refractory multiple myeloma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0205336
UMLS CUI [2]
C0278620
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
smoldering mm.
Description

Smoldering myeloma

Type de données

boolean

Alias
UMLS CUI [1]
C1531608
multiple myeloma that does not express m-protein or free light chain(flc) (i.e., non-secretory mm is excluded), and quantitative immunoglobulin levels cannot be used instead.
Description

Multiple Myeloma | Gene Expression | M Protein | Free Immunoglobulin Light Chain | Non-secretory myeloma | Immunoglobulin level Quantitative

Type de données

boolean

Alias
UMLS CUI [1]
C0026764
UMLS CUI [2]
C0017262
UMLS CUI [3]
C0700271
UMLS CUI [4]
C0806492
UMLS CUI [5]
C0456845
UMLS CUI [6,1]
C0428536
UMLS CUI [6,2]
C0392762
documented systemic amyloid light chain amyloidosis.
Description

Primary amyloidosis of light chain type Systemic | Amyloid

Type de données

boolean

Alias
UMLS CUI [1,1]
C0342606
UMLS CUI [1,2]
C0205373
UMLS CUI [2]
C0002716
active mm involving the central nervous system (cns).
Description

Multiple Myeloma Involvement with Central Nervous System

Type de données

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C3714787
plasma cell leukemia.
Description

Leukemia, Plasma Cell

Type de données

boolean

Alias
UMLS CUI [1]
C0023484
on the selinexor + dexamethasone + bortezomib (sdb) arm only: prior history of neuropathy grade > 2, or grade 2 neuropathy with pain at baseline (within 14 days prior to cycle 1 day 1).
Description

Protocol Treatment Arm selinexor Dexamethasone bortezomib | Neuropathy | Neuropathy, Painful

Type de données

boolean

Alias
UMLS CUI [1,1]
C1522541
UMLS CUI [1,2]
C3852671
UMLS CUI [1,3]
C0011777
UMLS CUI [1,4]
C1176309
UMLS CUI [2]
C0442874
UMLS CUI [3]
C1850383
Retour au début de la page

Similar models

Eligibility Multiple Myeloma NCT02343042

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diagnosis Histology | Measurable Disease | Multiple Myeloma | Disease Progression
Item
histologically confirmed diagnosis, measurable disease and evidence of disease progression of multiple myeloma, as described below.
boolean
C0011900 (UMLS CUI [1,1])
C0344441 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
C0242656 (UMLS CUI [4])
Multiple Myeloma Symptomatic | Measurable Disease
Item
symptomatic multiple myeloma, based on imwg guidelines. patients must have measurable disease as defined by at least one of the following:
boolean
C0026764 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2])
M Protein | Serum protein electrophoresis | IgA myeloma | Immunoglobulin A measurement Quantitative
Item
1. serum m-protein ≥ 5 g/l by serum electrophoresis (spep) or for immunoglobulin a (iga) myeloma, by quantitative iga; or
boolean
C0700271 (UMLS CUI [1])
C0201720 (UMLS CUI [2])
C0563305 (UMLS CUI [3])
C0202083 (UMLS CUI [4,1])
C0392762 (UMLS CUI [4,2])
Excretion measurement M Protein In Urine
Item
2. urinary m-protein excretion at least 200 mg/24 hours; or
boolean
C0201808 (UMLS CUI [1,1])
C0700271 (UMLS CUI [1,2])
C0042037 (UMLS CUI [1,3])
Serum Free Immunoglobulin Light Chain Involvement | Serum Immunoglobulin Free Light Chain Ratio Abnormal
Item
3. involved serum free light chains ≥ 100 mg/l, provided that free light chain ratio is abnormal
boolean
C2827352 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C2826181 (UMLS CUI [2])
Serum protein electrophoresis unreliable | M Protein Measurement | Immunoglobulin level Quantitative | Nephelometry | Turbidimetry
Item
4. if serum protein electrophoresis is felt to be unreliable for routine m-protein measurement, then quantitative immunoglobulin levels by nephelometry or turbidometry are acceptable.
boolean
C0201720 (UMLS CUI [1,1])
C0749770 (UMLS CUI [1,2])
C0700271 (UMLS CUI [2,1])
C0242485 (UMLS CUI [2,2])
C0428536 (UMLS CUI [3,1])
C0392762 (UMLS CUI [3,2])
C0027692 (UMLS CUI [4])
C0041394 (UMLS CUI [5])
Resolution Toxic effect Due to Pharmaceutical Preparations
Item
resolution of prior drug-related toxicities to ≤ grade 1.
boolean
C1514893 (UMLS CUI [1,1])
C0600688 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,4])
Multiple Myeloma Relapsed | Refractory multiple myeloma
Item
relapsed and/or refractory multiple myeloma.
boolean
C0026764 (UMLS CUI [1,1])
C0205336 (UMLS CUI [1,2])
C0278620 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Smoldering myeloma
Item
smoldering mm.
boolean
C1531608 (UMLS CUI [1])
Multiple Myeloma | Gene Expression | M Protein | Free Immunoglobulin Light Chain | Non-secretory myeloma | Immunoglobulin level Quantitative
Item
multiple myeloma that does not express m-protein or free light chain(flc) (i.e., non-secretory mm is excluded), and quantitative immunoglobulin levels cannot be used instead.
boolean
C0026764 (UMLS CUI [1])
C0017262 (UMLS CUI [2])
C0700271 (UMLS CUI [3])
C0806492 (UMLS CUI [4])
C0456845 (UMLS CUI [5])
C0428536 (UMLS CUI [6,1])
C0392762 (UMLS CUI [6,2])
Primary amyloidosis of light chain type Systemic | Amyloid
Item
documented systemic amyloid light chain amyloidosis.
boolean
C0342606 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0002716 (UMLS CUI [2])
Multiple Myeloma Involvement with Central Nervous System
Item
active mm involving the central nervous system (cns).
boolean
C0026764 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C3714787 (UMLS CUI [1,3])
Leukemia, Plasma Cell
Item
plasma cell leukemia.
boolean
C0023484 (UMLS CUI [1])
Protocol Treatment Arm selinexor Dexamethasone bortezomib | Neuropathy | Neuropathy, Painful
Item
on the selinexor + dexamethasone + bortezomib (sdb) arm only: prior history of neuropathy grade > 2, or grade 2 neuropathy with pain at baseline (within 14 days prior to cycle 1 day 1).
boolean
C1522541 (UMLS CUI [1,1])
C3852671 (UMLS CUI [1,2])
C0011777 (UMLS CUI [1,3])
C1176309 (UMLS CUI [1,4])
C0442874 (UMLS CUI [2])
C1850383 (UMLS CUI [3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial